Want to see JP:6039 full AI Analyst Report?
Japan Animal Referral Medical Center Co., Ltd. (6039) Ratios
0 Followers
Japan Animal Referral Medical Center Co., Ltd. Ratios
JP:6039's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:6039's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.56 | 1.03 | 1.16 | 1.89 | 1.59 |
| Quick Ratio | 0.54 | 0.97 | 1.09 | 1.79 | 1.46 |
| Cash Ratio | 0.43 | 0.71 | 0.87 | 1.51 | 1.11 |
| Solvency Ratio | 0.22 | 0.24 | 0.16 | 0.16 | 0.11 |
| Operating Cash Flow Ratio | 0.37 | 0.88 | 0.58 | 0.64 | 0.58 |
| Short-Term Operating Cash Flow Coverage | 0.52 | 2.19 | 1.44 | 1.39 | 1.02 |
| Net Current Asset Value | ¥ -4.32B | ¥ -3.01B | ¥ -3.18B | ¥ -2.48B | ¥ -3.06B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.46 | 0.40 | 0.44 | 0.46 | 0.55 |
| Debt-to-Equity Ratio | 1.06 | 0.84 | 1.01 | 1.07 | 1.56 |
| Debt-to-Capital Ratio | 0.51 | 0.46 | 0.50 | 0.52 | 0.61 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.41 | 0.46 | 0.48 | 0.57 |
| Financial Leverage Ratio | 2.32 | 2.11 | 2.30 | 2.31 | 2.83 |
| Debt Service Coverage Ratio | 0.53 | 1.66 | 1.27 | 1.36 | 0.95 |
| Interest Coverage Ratio | 28.81 | 24.06 | 22.49 | 34.15 | 18.14 |
| Debt to Market Cap | 0.34 | 0.52 | 0.72 | 0.90 | 0.91 |
| Interest Debt Per Share | 402.26 | 270.62 | 282.98 | 327.94 | 332.70 |
| Net Debt to EBITDA | 2.05 | 1.83 | 2.58 | 2.13 | 4.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.49% | 34.31% | 34.29% | 37.26% | 37.11% |
| EBIT Margin | 18.57% | 13.66% | 11.95% | 14.24% | 14.63% |
| EBITDA Margin | 28.08% | 24.47% | 22.90% | 24.98% | 22.72% |
| Operating Profit Margin | 18.57% | 13.66% | 11.64% | 14.99% | 14.74% |
| Pretax Profit Margin | 18.44% | 13.65% | 11.51% | 13.79% | 14.22% |
| Net Profit Margin | 13.46% | 9.87% | 7.90% | 9.83% | 9.63% |
| Continuous Operations Profit Margin | 13.46% | 9.87% | 7.90% | 9.83% | 9.63% |
| Net Income Per EBT | 72.98% | 72.33% | 68.64% | 71.29% | 67.74% |
| EBT Per EBIT | 99.29% | 99.90% | 98.87% | 91.97% | 96.44% |
| Return on Assets (ROA) | 7.37% | 5.95% | 3.85% | 4.44% | 4.04% |
| Return on Equity (ROE) | 17.07% | 12.56% | 8.85% | 10.27% | 11.43% |
| Return on Capital Employed (ROCE) | 15.18% | 10.01% | 6.87% | 7.94% | 7.15% |
| Return on Invested Capital (ROIC) | 8.18% | 6.66% | 4.34% | 5.24% | 4.45% |
| Return on Tangible Assets | 7.75% | 6.30% | 4.10% | 4.78% | 4.45% |
| Earnings Yield | 5.51% | 7.78% | 6.31% | 8.58% | 6.69% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.28 | 16.53 | 14.75 | 15.26 | 13.47 |
| Payables Turnover | 51.16 | 52.71 | 47.80 | 29.17 | 28.54 |
| Inventory Turnover | 39.45 | 36.61 | 28.82 | 19.16 | 14.54 |
| Fixed Asset Turnover | 0.75 | 0.84 | 0.69 | 0.73 | 0.63 |
| Asset Turnover | 0.55 | 0.60 | 0.49 | 0.45 | 0.42 |
| Working Capital Turnover Ratio | -7.82 | 37.35 | 6.25 | 4.55 | 5.33 |
| Cash Conversion Cycle | 23.24 | 25.12 | 29.77 | 30.45 | 39.41 |
| Days of Sales Outstanding | 21.12 | 22.08 | 24.74 | 23.91 | 27.10 |
| Days of Inventory Outstanding | 9.25 | 9.97 | 12.66 | 19.05 | 25.10 |
| Days of Payables Outstanding | 7.13 | 6.92 | 7.64 | 12.51 | 12.79 |
| Operating Cycle | 30.37 | 32.05 | 37.40 | 42.97 | 52.20 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 108.00 | 105.96 | 65.65 | 66.61 | 47.01 |
| Free Cash Flow Per Share | -73.77 | 32.33 | -11.34 | 5.67 | -3.74 |
| Dividend Paid and CapEx Coverage Ratio | 0.57 | 1.36 | 0.81 | 1.09 | 0.93 |
| Capital Expenditure Coverage Ratio | 0.59 | 1.44 | 0.85 | 1.09 | 0.93 |
| Operating Cash Flow Coverage Ratio | 0.27 | 0.39 | 0.23 | 0.20 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.26 | 0.21 | 0.21 | 0.19 |
| Free Cash Flow Yield | -6.31% | 6.26% | -2.91% | 1.55% | -1.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.14 | 12.85 | 15.84 | 11.65 | 14.94 |
| Price-to-Sales (P/S) Ratio | 2.44 | 1.27 | 1.25 | 1.15 | 1.44 |
| Price-to-Book (P/B) Ratio | 3.10 | 1.61 | 1.40 | 1.20 | 1.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.86 | 15.99 | -34.36 | 64.31 | -96.63 |
| Price-to-Operating Cash Flow Ratio | 10.83 | 4.88 | 5.93 | 5.47 | 7.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.30 | 0.20 | -0.74 | 0.40 | 81.98 |
| Enterprise Value Multiple | 10.75 | 7.01 | 8.04 | 6.71 | 10.55 |
| Enterprise Value | 18.69B | 9.06B | 7.86B | 6.50B | 7.14B |
| EV to EBITDA | 10.75 | 7.01 | 8.04 | 6.71 | 10.55 |
| EV to Sales | 3.02 | 1.72 | 1.84 | 1.68 | 2.40 |
| EV to Free Cash Flow | -19.60 | 21.64 | -50.57 | 94.17 | -160.94 |
| EV to Operating Cash Flow | 13.39 | 6.60 | 8.73 | 8.01 | 12.81 |
| Tangible Book Value Per Share | 334.73 | 283.29 | 238.09 | 254.44 | 155.51 |
| Shareholders’ Equity Per Share | 377.70 | 320.31 | 278.07 | 304.40 | 211.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.28 | 0.31 | 0.29 | 0.32 |
| Revenue Per Share | 479.14 | 407.49 | 311.54 | 318.11 | 251.16 |
| Net Income Per Share | 64.49 | 40.22 | 24.60 | 31.27 | 24.19 |
| Tax Burden | 0.73 | 0.72 | 0.69 | 0.71 | 0.68 |
| Interest Burden | 0.99 | 1.00 | 0.96 | 0.97 | 0.97 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.22 | 0.19 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.67 | 2.63 | 2.67 | 2.13 | 1.95 |
Currency in JPY
